ArticleOncology and therapy2024

A Patient-Relevant Measurement Strategy to Assess Clinical Benefit of Novel Therapies for Non-metastatic Cutaneous Squamous Cell Carcinoma.

Diana Rofail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.